Philip Morris Plans to Abandon Traditional Cigarette Business

May.29.2023

Philip Morris International (PMI) will abandon traditional cigarettes for risk-reduced products and call for stricter regulations on disposable e-cigarettes.

Recently, the German newspaper "Die Welt" reported that Philip Morris International (PMI) decided to abandon its traditional cigarette business in favor of new heated tobacco devices and called for strict regulation of disposable e-cigarettes.

Markus Essing, CEO of PMI Germany and Austria, stated at an event in Berlin.

We will be exiting the tobacco business and only offering reduced-risk products.

The manager did not specify a specific time frame, stating "we can set a deadline, but the specific date has not yet been determined.

PMI differs from other large tobacco companies such as British American Tobacco or Japan Tobacco in this regard.

Since 2017, the company has ceased advertising for traditional cigarettes such as Marlboro and has mainly focused on the IQOS heated tobacco device. PMI claims that harmful substances are reduced by 95% compared to traditional cigarettes because the tobacco in the device is heated instead of burned.

Reference:

Philip Morris to end production of Marlboro cigarettes

#Asia #India #Open system e-cigarettes #Regulation #Traditional tobacco products

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South

Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.

Nov.19

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

The WHO's first global estimate on October 6 showed over 100 million people use e-cigarettes, including at least 15 million adolescents (aged 13–15). The report warned that in reporting countries, children are nine times more likely to vape than adults.

Oct.07 by 2FIRSTS.ai

Geek Bar Launches New Pulse Models in the U.S.: Thermochromic Design, Core Specs Intact

U.S. vape retailer VapeSourcing has listed GEEKBAR Pulse 15K/25K Thermal Edition products, currently marked “Coming Soon.” Both models retain the core Pulse-series configuration but adopt a thermochromic, color-changing shell; the Pulse 15K is flagged as GEEKBAR’s first device to use this finish.

Nov.04 by 2FIRSTS.ai